Mitochondria-targeted hydrogen sulfide donor reduces atherogenesis by reprogramming macrophages and increasing UCP1 expression in vascular smooth muscle cells
Aneta Stachowicz, Anna Wiśniewska, Klaudia Czepiel, Bartosz Pomierny, Alicja Skórkowska, Beata Kuśnierz‐Cabala, Marcin Surmiak, Katarzyna Kuś, Mark E. Wood, Roberta Torregrossa, Matthew Whiteman, Rafał Olszanecki
This study shows that the mitochondrial H2S donor AP39 reduces atherosclerosis by reprogramming macrophages and increasing UCP1 in vascular smooth muscle cells.
Biomedicine & Pharmacotherapy · Oct 13, 2024Peer-reviewedPharmacology & Toxicology